Skip to main content

Want a detailed portfolio tracker?

Telomir Pharmaceuticals (TELO) P/E (2024 - 2026)

Telomir Pharmaceuticals (TELO) P/E from Feb 9, 2024 to Jul 20, 2026. The TTM Telomir Pharmaceuticals (TELO) P/E is -2.77. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Telomir Pharmaceuticals (TELO)

YearP/EChange
2026-2.77-30.89%
2025-4.01-45.74%
2024-7.39N/A

Comparison Telomir Pharmaceuticals (TELO) P/E with competitors

Telomir Pharmaceuticals (TELO) P/E is -2.77.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.16%
ENLVEnlivex Ltd0.07-102.70%
FGENFibroGen Inc0.24-108.67%
CHRSCoherus Biosciences Inc0.85-130.63%
FBIOFortress Biotech Inc0.95-134.26%
ORMPOramed Pharmaceuticals Inc1.50-154.26%
AGENAgenus Inc3.01-208.64%
INVAInnoviva Inc3.15-213.86%
VXRTVaxart Inc3.55-228.14%
CRMDCorMedix Inc3.63-230.98%
CVACCureVac N.V.4.45-260.48%
GLPGGalapagos NV4.86-275.40%
SRPTSarepta Therapeutics Inc4.88-276.24%
ABEOAbeona Therapeutics Inc5.39-294.48%
ABUSArbutus Biopharma Corp5.60-301.99%
ZVRAZevra Therapeutics Inc5.89-312.52%
SPROSpero Therapeutics Inc6.23-324.84%
CGENCompugen Ltd6.31-327.92%
RIGLRigel Pharmaceuticals6.87-348.07%
SLXNSilexion Therapeutics Corp7.30-363.38%
OMEROmeros Corporation9.26-434.23%
AUPHAurinia Pharmaceuticals Inc9.58-446.00%
PLXProtalix BioTherapeutics Inc10.89-493.15%
ACADAcadia Pharmaceuticals Inc11.73-523.38%
TBPHTheravance Biopharma Inc12.26-542.64%
ADMAAdma Biologics Inc12.42-548.28%
HRMYHarmony Biosciences Holdings Inc13.82-598.89%
SABSSAB Biotherapeutics Inc14.14-610.30%
NAGENiagen Bioscience Inc14.82-634.91%
INCYIncyte Corp15.82-671.17%
REGNRegeneron Pharmaceuticals Inc15.86-672.40%
PBYIPuma Biotechnology Inc17.32-725.07%
CPRXCatalyst Pharmaceuticals Inc17.44-729.53%
EXELExelixis Inc17.54-733.10%
TGTXTG Therapeutics Inc18.97-784.65%
MDXGMimedx Group Inc20.55-841.92%
XOMAXOMA Royalty Corp22.87-925.76%
ARGXArgen X SE24.30-977.15%
CTMXCytomX Therapeutics Inc24.82-996.03%
XOMAOXOMA Royalty Corp25.34-1014.93%
HALOHalozyme Therapeutics Inc25.62-1025.00%
XOMAPXOMA Royalty Corp25.67-1026.68%
VRTXVertex Pharmaceuticals Inc27.99-1110.60%
RPRXRoyalty Pharma plc - Class A28.69-1135.61%
SLNOSoleno Therapeutics Inc29.02-1147.44%
ASNDAscendis Pharma A/S30.09-1186.07%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1468.60%
APLSApellis Pharmaceuticals Inc39.02-1508.65%
BMRNBiomarin Pharmaceutical Inc42.21-1623.83%
KRYSKrystal Biotech Inc45.34-1736.88%
ONCBeiGene Ltd69.54-2610.37%
PHARPharming Group N.V.75.03-2808.39%
VCELVericel Corp109.92-4068.11%
ALNYAlnylam Pharmaceuticals Inc117.96-4358.48%
GMABGenmab140.29-5164.43%
TLXTelix Pharmaceuticals Ltd162.15-5953.64%
CORTCorcept Therapeutics Inc212.86-7784.05%